
Andries Kevenaar
Founding Partner — Strategic Market Approaches & Commerce
Registered pharmacist (BIG-register).
Detailed biography to be added.
Every year, marketing authorisation holders abandon products that patients depend on. The reasons are commercial — the product is too small, the market too fragmented, the regulatory burden too high relative to revenue. The consequences are medical — patients lose access to medicines they need.
New EU legislation aims to address this through reporting obligations and shortage prevention mechanisms. But legislation creates obligations — it doesn’t create companies willing to take on the products themselves.
Octopus Health is that company. We acquire the marketing authorisations, manage every regulatory obligation, control the supply chain, and — when no other channel works — dispense directly to patients through our own licensed pharmacy. One company. No gaps.

Our operations are based in Soesterberg, centrally located in the Netherlands. From here we hold our GDP licence, operate our dispensing pharmacy, and coordinate EU-wide regulatory and supply chain activities.
No layers. No committees. The people who hold the authorisations, assess the science, and make the decisions.

Founding Partner — Strategic Market Approaches & Commerce
Registered pharmacist (BIG-register).
Detailed biography to be added.

Founding Partner — Quality & Regulatory
Registered pharmacist (BIG-register).
Detailed biography to be added.

Founding Partner — Finance & EU Growth
Detailed biography to be added.
The Netherlands serves as our regulatory and operational home base. Through MRP and DCP procedures, we extend marketing authorisations from the Netherlands to other EU member states. Our GDP licence enables EU-wide distribution from a single hub.
Netherlands
Belgium · Germany · Austria
Scandinavia · Iberian Peninsula
Other EU / EEA (per product)